Autolus Therapeutics plc (AUTL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 529.62M |
| Enterprise Value | 777.07M |
| P/E Ratio | -1.23 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 2.31 |
| Price/Book Ratio | 11.56 |
| Enterprise/Revenue | 1.6 |
| Enterprise/EBITDA | -1.11 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -1.86 |
| Operating Margin | -1.6 |
| Return On Assets | -0.49 |
| Return On Equity | -2.63 |
| Revenue | 75.56M |
| Revenue/Share | 0.52 |
| Gross Profit | -21.03M |
| EBITDA | -250.28M |
| Net Income | -288.2M |
| Diluted EPS | -1.08 |
| Total Cash | 248.38M |
| Total Cash/Share | 0.93 |
| Total Debt | 147.87M |
| Total Debt/Equity | 5.4 |
| Current Ratio | 3.72 |
| Book Value Per Share | 0.1 |
| 52-Week Change | -12.5 |
| 52-Week High | 2.58 |
| 52-Week Low | 1.12 |
| Moving Average 50 Days | 1.74 |
| Moving Average 200 Days | 1.66 |
| Average Volume | 2.13M |
| Shares Outstanding | 266.16M |
| % Held by Institutions | 49.67 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |